Skip to content

Chronic fatigue and return to work in cancer survivors

Chronic fatigue and return to work in cancer survivors - Cancer and work

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35940
Enrollment
400
Registered
2011-06-22
Start date
2011-07-18
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer tumor

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The study population of the prospective cohort study (n=400) will exist of cancer survivors who apply for a WIA benefit at the head office of UWV in Amsterdam, i.e., they approach a 104 weeks period of sick leave and make a first application for WIA benefit.

Exclusion criteria

Exclusion criteria: 1. Clients treated for cancer, who are too ill to visit the UWV office for the WIA assessment. 2. Clients treated for cancer, who do an appeal on WIA benefit due to another somatic or psychiatric disorder. 3. Clients treated for cancer, with prior WAO/WIA benefit. 4. Clients treated for cancer, who are voluntarily insured non-employees. 5. Clients receiving chemo- or radiotherapy

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of the study is the level of fatigue, measured by the Functional Assessment of Cancer Therapy-Fatigue (FACT-F) scale. This 13-item scale is measured on a 5-point scale (range 0-52) , with 0 being the worst possible score and 52 the best.

Secondary

MeasureTime frame
- perceived work ability, which will be assessed using the first three questions of the Work Ability Index (WAI). - disability percentage, which is expressed by the percentage of income-loss of the previous job held. - depression, which will be measured by the Center for Epidemiological Studies - Depression scale (CES-D). The CES-D is a 20-items questionnaire, measured on a four-point scale. - quality of life, which will be assessed with the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C-30). This 30-item list incorporates nine multi-item scales: five functional scales; three symptom scales and a global health and quality-of-life scale. - coping, which will be measured with the Utrecht Coping List (UCL). The UCL has 47 statements covering seven coping strategies and is scored on a four-point scale. - work load, work stress and need for recovery. Physical workload will be measured with a seven-item scale, and work stress and need for recovery will both be measured with a 11-item scale from the Dutch questionnaire on Experience and Judgement of Work (VBBA). - supervisor and co-worker social support will be measured with two subscales (four items each) of a validated Dutch version of the Job Content Questionnaire (JCQ). - physical limitations, which will be measured with the mobility and ambulation subscales of the Sickness Impact Profile (SIP). The SIP uses a series of questions with two domains, i.e., physical and psychosocial. Other study parameters Both at baseline and one year follow-up, sociodemographics, disease-related data, working hours, and disability percentage, as assessed by UWV, will be gathered. Additional UWV file data, such as reintegration efforts, objection and appeal procedures, and Functional Ability Lists will also be gathered.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)